Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
The Simpson Querrey Center for Epigenetics is connecting the Northwestern academic and medical community to integrate the study of epigenetics into science and clinical care.
An emergency thrombectomy, which surgically removes large blood clots, may be beneficial in far more stroke patients than previously thought, according to a new trial.
Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
Scientists used a new approach to identify a promising therapeutic target for glioblastoma, which was previously overlooked in traditional approaches.
Kelsey Bowman extended her medical school program from four years to five years to develop a test to map regions of the brain associated with memory.